Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster Synflorix co-administered with Infanrix-IPV/Hib in preterm toddlers
2007-000596-42Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of 10-valent pneumococcal conjugate vaccine and diphtheria + tetanus + acellular pertussis + inactivated poliomyelitis + Haemophilus influenzae type b vaccine in pneumococcal disease, diphtheria, Tetanus and 3 more, sponsored by GSK. Primary endpoint: Occurrence of core fever after booster vaccination. Started Jun 2007; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccinediphtheria + tetanus + acellular pertussis + inactivated poliomyelitis + Haemophilus influenzae type b vaccine
03
Conditions
pneumococcal diseasediphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on 2007-000596-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000596-42.